GnRH agonist versus GnRH antagonist in ovarian stimulation: the role of elevated peak serum progesterone levels

Raoul OrvietoDepartment of Obstetrics and Gynecology, Barzilai Medical Center, Ashkelon, Israel, and Faculty of Health Sciences, Ben Gurion University of the Negev Beer ShevaIsraelCorrespondence[email protected]

Ravit NahumDepartment of Obstetrics and Gynecology, Barzilai Medical Center, Ashkelon, Israel, and Faculty of Health Sciences, Ben Gurion University of the Negev Beer ShevaIsrael

Simion MeltzerDepartment of Obstetrics and Gynecology, Barzilai Medical Center, Ashkelon, Israel, and Faculty of Health Sciences, Ben Gurion University of the Negev Beer ShevaIsrael

Gadi LibertyDepartment of Obstetrics and Gynecology, Barzilai Medical Center, Ashkelon, Israel, and Faculty of Health Sciences, Ben Gurion University of the Negev Beer ShevaIsrael

Eyal Y. AntebyDepartment of Obstetrics and Gynecology, Barzilai Medical Center, Ashkelon, Israel, and Faculty of Health Sciences, Ben Gurion University of the Negev Beer ShevaIsrael

Efraim ZohavDepartment of Obstetrics and Gynecology, Barzilai Medical Center, Ashkelon, Israel, and Faculty of Health Sciences, Ben Gurion University of the Negev Beer ShevaIsrael

References

Venetis CA, Kolibianakis EM, Papanikolaou E, et al. Is progesterone elevation on the day of human chorionic gonadotrophin administration associated with the probability of pregnancy in in vitro fertilization? A systematic review and meta-analysis. Hum Reprod Update 2007;13:343–55
PubMed Web of Science ®Google Scholar
Bosch E, Labarta E, Crespo J, et al. Circulating progesterone levels and ongoing pregnancy rates in controlled ovarian stimulation cycles for in vitro fertilization: analysis of over 4000 cycles. Hum Reprod 2010;25:2092–100
PubMed Web of Science ®Google Scholar
Kolibianakis EM, Venetis CA, Bontis J, Tarlatzis BC. Significantly lower pregnancy rates in the presence of progesterone elevation in patients treated with GnRH antagonists and gonadotrophins: a systematic review and meta-analysis. Curr Pharm Biotechnol 2012;13:464–70
PubMed Web of Science ®Google Scholar
Fleming R, Jenkins J. The source and implications of progesterone rise during the follicular phase of assisted reproduction cycles. RBM Online 2010;21:446–9
Google Scholar
Orvieto R, Meltcer S, Rabinson J, et al. GnRH agonist versus GnRH antagonist in ovarian stimulation: the role of endometrial receptivity? Fertil Steril 2008;90:1294–6
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

GnRH agonist versus GnRH antagonist in ovarian stimulation: the role of elevated peak serum progesterone levels

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

GnRH agonist versus GnRH antagonist in ovarian stimulation: the role of elevated peak serum progesterone levels

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date